APO RESEARCH · REPORT
Cyazofamid
Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.
Product & engineering
Understand the product.
Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.
Cyazofamid, discovered and developed by ISHIHARA SANGYO KAISHA on the global basis after first launched in 2001, is often used in downy mildew, oomycetes diseases, pepper and others.
Cyazofamid has good toxicological, environmental and ecotoxicological profiles.
In this report, we count technical grade and chapter 6 displays the preparation content.
Selected research
Market Structure
Global Cyazofamid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.
Cyazofamid, discovered and developed by ISHIHARA SANGYO KAISHA on the global basis after first launched in 2001, is often used in downy mildew, oomycetes diseases, pepper and others.
Cyazofamid has good toxicological, environmental and ecotoxicological profiles.
Read the full market overview
In this report, we count technical grade and chapter 6 displays the preparation content.
ISHIHARA SANGYO KAISHA is the largest manufacturer in the global market, with the share of 81%.
The consumption shares of Japan, China, North America and Europe were 42%, 21%, 17% and 11%. Japan is the main import region and other countries need to import from Japan.
The report provides an overview of the global Cyazofamid market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cyazofamid and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cyazofamid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cyazofamid market size, projected growth trends, production technologies, key applications, and end-use industries.
Cyazofamid Segment by Company
ISHIHARA SANGYO KAISHA
Rudong Zhongyi
Cyazofamid Segment by Type
Agriculture Grade
Others
Cyazofamid Segment by Application
Downy Mildew
Oomycetes Diseases
Others
Cyazofamid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyazofamid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cyazofamid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyazofamid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Cyazofamid market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cyazofamid industry.
Chapter 3: Detailed analysis of Cyazofamid market competition landscape. Including Cyazofamid manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Cyazofamid by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Cyazofamid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Agriculture Grade
- Others
Applications
- Downy Mildew
- Oomycetes Diseases
- Others
Companies covered
- ISHIHARA SANGYO KAISHA
- Rudong Zhongyi
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Cyazofamid Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Cyazofamid Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Cyazofamid Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Cyazofamid Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Cyazofamid Market Dynamics
- 2.1 Cyazofamid Industry Trends
- 2.2 Cyazofamid Industry Drivers
- 2.3 Cyazofamid Industry Opportunities and Challenges
- 2.4 Cyazofamid Industry Restraints
3 Cyazofamid Market by Manufacturers
- 3.1 Global Cyazofamid Production Value by Manufacturers (2021-2026)
- 3.2 Global Cyazofamid Production by Manufacturers (2021-2026)
- 3.3 Global Cyazofamid Average Price by Manufacturers (2021-2026)
- 3.4 Global Cyazofamid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cyazofamid Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Cyazofamid Manufacturers, Product Type & Application
- 3.7 Global Cyazofamid Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cyazofamid Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cyazofamid Players Market Share by Production Value in 2025
- 3.8.3 2025 Cyazofamid Tier 1, Tier 2, and Tier 3
4 Cyazofamid Market by Type
- 4.1 Cyazofamid Type Introduction
- 4.1.1 Agriculture Grade
- 4.1.2 Others
- 4.2 Global Cyazofamid Production by Type
- 4.2.1 Global Cyazofamid Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cyazofamid Production by Type (2021-2032)
- 4.2.3 Global Cyazofamid Production Market Share by Type (2021-2032)
- 4.3 Global Cyazofamid Production Value by Type
- 4.3.1 Global Cyazofamid Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Cyazofamid Production Value by Type (2021-2032)
- 4.3.3 Global Cyazofamid Production Value Market Share by Type (2021-2032)
5 Cyazofamid Market by Application
- 5.1 Cyazofamid Application Introduction
- 5.1.1 Downy Mildew
- 5.1.2 Oomycetes Diseases
- 5.1.3 Others
- 5.2 Global Cyazofamid Production by Application
- 5.2.1 Global Cyazofamid Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cyazofamid Production by Application (2021-2032)
- 5.2.3 Global Cyazofamid Production Market Share by Application (2021-2032)
- 5.3 Global Cyazofamid Production Value by Application
- 5.3.1 Global Cyazofamid Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Cyazofamid Production Value by Application (2021-2032)
- 5.3.3 Global Cyazofamid Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 ISHIHARA SANGYO KAISHA
- 6.1.1 ISHIHARA SANGYO KAISHA Company Information
- 6.1.2 ISHIHARA SANGYO KAISHA Business Overview
- 6.1.3 ISHIHARA SANGYO KAISHA Cyazofamid Production, Value and Gross Margin (2021-2026)
- 6.1.4 ISHIHARA SANGYO KAISHA Cyazofamid Product Portfolio
- 6.1.5 ISHIHARA SANGYO KAISHA Recent Developments
- 6.2 Rudong Zhongyi
- 6.2.1 Rudong Zhongyi Company Information
- 6.2.2 Rudong Zhongyi Business Overview
- 6.2.3 Rudong Zhongyi Cyazofamid Production, Value and Gross Margin (2021-2026)
- 6.2.4 Rudong Zhongyi Cyazofamid Product Portfolio
- 6.2.5 Rudong Zhongyi Recent Developments
7 Global Cyazofamid Production by Region
- 7.1 Global Cyazofamid Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Cyazofamid Production by Region (2021-2032)
- 7.2.1 Global Cyazofamid Production by Region (2021-2026)
- 7.2.2 Global Cyazofamid Production Forecast by Region (2027-2032)
- 7.3 Global Cyazofamid Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Cyazofamid Production Value by Region (2021-2032)
- 7.4.1 Global Cyazofamid Production Value by Region (2021-2026)
- 7.4.2 Global Cyazofamid Production Value by Region (2027-2032)
- 7.5 Global Cyazofamid Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Cyazofamid Production Value (2021-2032)
- 7.6.2 Europe Cyazofamid Production Value (2021-2032)
- 7.6.3 Asia-Pacific Cyazofamid Production Value (2021-2032)
- 7.6.4 South America Cyazofamid Production Value (2021-2032)
- 7.6.5 Middle East & Africa Cyazofamid Production Value (2021-2032)
8 Global Cyazofamid Consumption by Region
- 8.1 Global Cyazofamid Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Cyazofamid Consumption by Region (2021-2032)
- 8.2.1 Global Cyazofamid Consumption by Region (2021-2026)
- 8.2.2 Global Cyazofamid Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Cyazofamid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Cyazofamid Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Cyazofamid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Cyazofamid Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Cyazofamid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Cyazofamid Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Cyazofamid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Cyazofamid Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Cyazofamid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Cyazofamid Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Cyazofamid Value Chain Analysis
- 9.1.1 Cyazofamid Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Cyazofamid Production Mode & Process
- 9.2 Cyazofamid Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cyazofamid Distributors
- 9.2.3 Cyazofamid Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst